微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 75.04% | 1591.85% | 1917.2% | 2/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 3.72% | 431.43% | 313.79% | 54/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -1.74% | 14.71% | 89.57% | 130/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -16.69% | 80.34% | -231.81% | 132/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -5.03% | -115.88% | -818.57% | 129/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 0.7% | 137.43% | 134.31% | 108/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -2.04% | -151.85% | 97.6% | 128/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -84.91% | -6436.57% | -3544.21% | 149/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -2.33% | -219.49% | -24.6% | 118/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -1.87% | -279.81% | -130.86% | 124/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -0.81% | -127.46% | -160.45% | 121/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.34% | -95.71% | -31.28% | 103/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 1.95% | -95.7% | 87.5% | 107/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.04% | -95.32% | -64.75% | 109/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.95% | -39.3% | -90.56% | 45/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 31.24% | 2% | -31.07% | 3/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 45.32% | 13633.33% | 104.05% | 1/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 22.21% | -59.05% | 357% | 3/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 4.86% | 2% | 2% | 15/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-03-31 | 0% | 100% | 2% | 102/160 | 2.46% | 誉衡药业 | 35.56% | 行业排名> |
| 2018-12-31 | 0% | 100% | -100% | 119/160 | 7.09% | 奥赛康 | 35% | 行业排名> |
| 2017-09-30 | 0.33% | 100.19% | -99.39% | 95/160 | 8.31% | 奥赛康 | 28.15% | 行业排名> |
| 2017-06-30 | 54.24% | 149.41% | 4942.86% | 1/160 | 5.59% | 宏源药业 | 21.91% | 行业排名> |
| 2017-03-31 | -1.12% | -105.81% | 99.78% | 85/160 | 2.1% | 奥赛康 | 9.7% | 行业排名> |
| 2016-12-31 | -504.73% | -743.47% | -188.09% | 113/160 | 6.33% | 奥赛康 | 40.69% | 行业排名> |
| 2016-09-30 | -175.2% | -477.84% | -59.59% | 81/160 | 5.61% | 信立泰 | 25.93% | 行业排名> |
| 2016-06-30 | -109.78% | -716.82% | -669.1% | 91/160 | 3.53% | 昂利康 | 15.91% | 行业排名> |
| 2016-03-31 | 19.29% | 355.84% | 132.24% | 1/160 | 2.65% | 奥赛康 | 12.08% | 行业排名> |
| 2015-12-31 | -59.84% | 6.24% | -97.36% | 104/160 | 11.35% | 一品红 | 31.62% | 行业排名> |
| 2015-09-30 | -30.32% | -391.82% | -125.6% | 78/160 | 7.22% | 丽珠集团 | 49.43% | 行业排名> |
| 2015-06-30 | -13.44% | 49.13% | -78.25% | 83/160 | 4.9% | 河化股份 | 54.24% | 行业排名> |
| 2015-03-31 | -7.54% | 4.8% | 88.19% | 75/160 | 2.41% | 华东医药 | 7.2% | 行业排名> |